share_log

RBC Capital Downgrades Marinus Pharma to Sector Perform, Lowers Price Target to $3

Moomoo 24/7 ·  Apr 15 14:52

RBC Capital analyst Brian Abrahams downgrades Marinus Pharma (NASDAQ:MRNS) from Outperform to Sector Perform and lowers the price target from $24 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment